Pain 3 Flashcards
T or F: Pain is an objective phenomenon that requires careful measurement and tx.
F
Pain is completely subjective and is whatever the pt says it is
List all therapeutic alternatives for chronic non-cancer pain:
Opioids, NSAIDs, acetaminophen, TCAs, SNRIs, anticonvulsants
Patient is on hydromorphone 10mg po daily. What’s their total daily morphine equivalents?
50mg MEQ
Patient with chronic back pain is taking Tylenol #3s (300mg acetaminophen/30mg codeine/15mg caffeine) 3 tabs po q4h for chronic back pain.
What is the patient’s total daily MEQ?
81mg MEQ
Current inpatient medication administration record for Patient A:
-Hydromorphone 1 mg subcut q4h scheduled-
What is Patient A’s total daily MEQ?
60mg MEQ
Current inpatient medication administration record for patient B: • Morphine 5mg IV intermittent q4h scheduled
• Oxycodone 5mg po q4h prn
• Used 3 x 5mg doses in last 24 hours
What is Patient B’s total MEQ in the last 24 hours?
82.5 mg MEQ
Patient C has is taking M-Eslon (morphine) SR 100 mg po q12h
• Patient C has declining renal function and her family physician is worried about CNS adverse effects of morphine and would like to change to hydromorphone
• What is the equivalent dose of hydromorphone that you would recommend for Patient C? (give dosing interval and prn dosing too)
20mg hydromorphone/d
10mg bid (q12h) (just like prev dosing regimen)
and 2mg q4-6h (10% of total daily dose)
Before turning to opioids, what must we do for pain tx?
Optimize non-opioid interventions first! > non-pharm and non-opioid tx FIRST!
T or F: Opioids are trialed and are not often intended to be used indefinitely
T
How long should an opioid trial be?
3-6 mths
Which opioids are first line for mild-mod pain?
codeine
Which opioids are first line for severe pain?
morphine, oxycodone, hydromorphone
Which opioids are second line for mild-mod pain?
morphine, oxycodone, hydromorphone
Which opioids are second line for severe pain?
fentanyl
Which opioids are third line for mild-mod pain?
No alternatives - stick w/ second-line and optimize non-pharm and non-opioid options